Vanguard Group’s The Oncology Institute TOI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $8.78M | Buy |
4,280,887
+2,530,173
| +145% | +$5.19M | ﹤0.01% | 2974 |
|
|
2025
Q1 | $2M | Sell |
1,750,714
-3,672
| -0.2% | -$4.19K | ﹤0.01% | 3490 |
|
|
2024
Q4 | $542K | Sell |
1,754,386
-29,068
| -2% | -$8.98K | ﹤0.01% | 3926 |
|
|
2024
Q3 | $583K | Hold |
1,783,454
| – | – | ﹤0.01% | 3931 |
|
|
2024
Q2 | $820K | Hold |
1,783,454
| – | – | ﹤0.01% | 3856 |
|
|
2024
Q1 | $2.82M | Buy |
1,783,454
+6,061
| +0.3% | +$9.58K | ﹤0.01% | 3485 |
|
|
2023
Q4 | $3.63M | Buy |
1,777,393
+19,359
| +1% | +$39.5K | ﹤0.01% | 3402 |
|
|
2023
Q3 | $2.46M | Sell |
1,758,034
-4,916
| -0.3% | -$6.88K | ﹤0.01% | 3514 |
|
|
2023
Q2 | $970K | Sell |
1,762,950
-180,593
| -9% | -$99.4K | ﹤0.01% | 3909 |
|
|
2023
Q1 | $1.32M | Buy |
1,943,543
+10,937
| +0.6% | +$7.41K | ﹤0.01% | 3829 |
|
|
2022
Q4 | $3.19M | Buy |
1,932,606
+72,364
| +4% | +$119K | ﹤0.01% | 3492 |
|
|
2022
Q3 | $8.61M | Buy |
1,860,242
+284,807
| +18% | +$1.32M | ﹤0.01% | 3026 |
|
|
2022
Q2 | $7.97M | Buy |
1,575,435
+737,114
| +88% | +$3.73M | ﹤0.01% | 3111 |
|
|
2022
Q1 | $5.98M | Buy |
838,321
+395,977
| +90% | +$2.82M | ﹤0.01% | 3445 |
|
|
2021
Q4 | $4.31M | Buy |
+442,344
| New | +$4.31M | ﹤0.01% | 3692 |
|